GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
9.94587 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
9.75099 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTAFR, RORC, SRC, TYR |
9.58504 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.40139 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.40139 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTAFR, RORC, SRC, TYR |
9.40139 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTAFR, RORC, SRC, TERT, TYR |
9.32621 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTAFR, RORC, SRC, TYR |
9.08654 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, XDH |
8.61929 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTAFR, SRC, TERT, XDH |
8.30769 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, PTAFR, RORC, SRC, TYR |
8.10494 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
8.00439 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SRC |
7.70092 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
7.53846 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, HCAR2, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.52821 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, HCAR2, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.50939 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TERT, TNKS2, TYR |
7.33023 |
[BP] GO:0044281 |
small molecule metabolic process
|
ADORA2A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GBA2, PIM1, PPARA, PTAFR, TYR, XDH |
7.19558 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
7.07945 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.76957 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.65136 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
6.40746 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC, TERT |
6.23976 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTAFR, RORC, SRC, TERT |
6.23383 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, PTAFR, SRC |
6.15738 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.15485 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, EGFR, HCAR2, KDR, SRC, TNKS, TNKS2 |
6.15301 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.05501 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
6.05501 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
6.04382 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
5.98377 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.98377 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.9636 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.85096 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.82154 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
5.78883 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.76878 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.74251 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PTAFR, RORC, SRC |
5.63089 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
5.62642 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, F3, FLT3, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.53164 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
5.51442 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.42806 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, ESR1, F3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTAFR, TERT |
5.42806 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.42806 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, F3, FABP4, FLT3, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.39275 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, RORC, SRC, TNKS2, TYR |
5.35722 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.27964 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
5.17387 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
5.14414 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
5.13898 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
5.06303 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SRC, TERT |
5.04934 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, PTAFR |
5.04264 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
5.00585 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
5.00585 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TYR |
4.97217 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADORA2A, AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, PTAFR, SRC |
4.97217 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTAFR, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.89379 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.86327 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
4.72564 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.69801 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.69801 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.55013 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTAFR, PTPN1, RORC, SRC, TERT |
4.50674 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTAFR, PTPN1, SRC, TNKS, XDH |
4.43805 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38039 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.36473 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.34867 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.32993 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KDR, MMP9, PTAFR, PTPN1, SRC, XDH |
4.27381 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KDR, MMP9, PTAFR, PTPN1, SRC, XDH |
4.27381 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, ERBB2, F3, FLT3, KDR, MET, PTPN1, SRC, XDH |
4.24308 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
4.22075 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTAFR, TERT |
4.18654 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.14211 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTAFR, PTPN1, SRC, TNKS, XDH |
4.13541 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CDK6, CYP1B1, DNMT1, EGFR, ESR1, IGF1R, MMP2, MMP9, PTAFR, RORC, SRC |
4.12264 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, HSD11B2, MMP2, PPARA, PTAFR, SRC, TERT, TYR |
4.12264 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TNKS, TNKS2 |
4.10338 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SRC, TYR |
4.09148 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.09148 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRB1, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, MET, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
4.0849 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
4.06432 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
4.06428 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.06233 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTAFR, RORC, SRC |
4.06233 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIM1, SRC, TYR |
4.05744 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7, PTAFR |
4.05744 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CDK6, CYP19A1, DYRK1A, EGFR, ESR1, F3, FABP4, IGF1R, MET, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
3.9933 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.94937 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.91969 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.91545 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, AXL, BCL2, CA2, CACNA1C, CDK6, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, HCAR2, KDR, MET, MMP9, PIM1, PTAFR, SRC, TERT, TNKS2, XDH |
3.90884 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, PPARA, RORC, SRC |
3.89253 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, CACNA1C, KDR, SRC |
3.89241 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADORA2A, ADRB1, APP, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, PPARA, PTAFR, RORC, SRC, TERT, TNKS, TNKS2 |
3.89241 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.85776 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.81244 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP2, MMP9, SRC, XDH |
3.8081 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SRC, TYR |
3.77939 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, PTAFR, SRC |
3.74739 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.73014 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, EGFR, ERBB2, HCAR2, PTAFR, SRC, TERT |
3.70876 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.69679 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTAFR, SRC |
3.68434 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.67257 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, AURKB, CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 |
3.66988 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FABP4, FLT3, IGF1R, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
3.6697 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.66373 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADORA2A, ADRB1, APP, AURKB, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2 |
3.65877 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.65877 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65877 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65877 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTAFR, PTPN1, SRC, XDH |
3.60356 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.56384 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, TERT |
3.56205 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTAFR, PTPN1, SRC, XDH |
3.56085 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, PTAFR, TYR |
3.54974 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ADRB1, ALPL, APP, AXL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, MMP2, MMP9, RORC, SRC, TERT |
3.54617 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, SRC |
3.53981 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.52818 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.5261 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.5261 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.49277 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADORA2A, ADRB1, APP, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, PPARA, PTAFR, RORC, SRC, TERT, TNKS, TNKS2 |
3.47892 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, IGF1R, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
3.47728 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
3.45283 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.43118 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.43118 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.39272 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, BCL2, CDK6, CYP19A1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.38207 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
3.36163 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, F3, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SRC, TNKS, TNKS2 |
3.36163 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.3599 |
[BP] GO:0048143 |
None
|
ADORA2A, APP, EGFR |
3.35755 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.35755 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC, TERT |
3.32968 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
3.32259 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.32159 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PTAFR, SRC |
3.30989 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7, EGFR |
3.27033 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, HCAR2, MMP9, PPARA, PTAFR, PTPN1, SRC, TERT |
3.25582 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC, TERT |
3.25582 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7 |
3.24657 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, ADRB1, APP, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, F3, HCAR2, KDR, MET, MMP9, PIM1, PTAFR, SRC, TERT |
3.2387 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23647 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.22921 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.18457 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTAFR, TERT |
3.14956 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, EGFR, KDR, PTAFR, SRC |
3.09973 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, F3, FLT3, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
3.07288 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC, TERT |
3.0046 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC, XDH |
2.96123 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
2.96123 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTAFR |
2.96123 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, KDR, MMP9, PTAFR, PTPN1, SRC, XDH |
2.94518 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.94228 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, EGFR |
2.91923 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, EGFR |
2.91923 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.90748 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC, TNKS |
2.90748 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.90748 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.90748 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.9023 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.9023 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, PPARA, PTAFR |
2.82651 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, PPARA, PTAFR, RORC, SRC, TERT, TNKS, TNKS2 |
2.82383 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.8198 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.79937 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC |
2.77841 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.73605 |
[BP] GO:0003018 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR, SRC |
2.73605 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.73558 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, KDR, MMP9, PTAFR, PTPN1, SRC, XDH |
2.71091 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.67275 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.66563 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.65863 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.65863 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.65863 |
[BP] GO:0003014 |
None
|
ADORA1, ADORA2A, AKR1B1, BCL2, HSD11B2 |
2.65733 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.63518 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.59818 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DNMT1, EGFR, ERBB2, ESR1, FLT3, IGF1R, MMP2, PTAFR, SRC |
2.58786 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.58739 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.58251 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.5752 |
[BP] GO:0097755 |
None
|
ADORA2A, ADRB1, EGFR, PTAFR |
2.56747 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.54638 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.52 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.50664 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CDK6, CYP1B1, ERBB2, FABP3, TERT, XDH |
2.48954 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.4895 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.4895 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.4841 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, CDK6, EGFR, ESR1, FLT3, PTAFR, RORC, SRC |
2.48149 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DYRK1A, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.48069 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.46853 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DYRK1A, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.46853 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.46708 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PTAFR, SRC |
2.45848 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.45848 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.45848 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.45838 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
2.44008 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.41245 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, PPARA |
2.39456 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, SRC |
2.38875 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2 |
2.37219 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9 |
2.36319 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC |
2.36319 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADORA2A, APP, AURKB, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, PTPN1, SRC, TNKS |
2.35895 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, CACNA1C, MMP9, PTAFR |
2.34415 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, DNMT1, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.33971 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, HSD11B2, MMP2, MMP9, PPARA, PTAFR, PTPN1, SRC, TERT |
2.31304 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.31155 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, ADORA2A, CYP19A1, EGFR, HCAR2, PTAFR, SRC |
2.30668 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.30617 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.30617 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.30224 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.30166 |
[BP] GO:0071229 |
cellular response to acid chemical
|
DNMT1, EGFR, KDR, MMP2, PTAFR, SRC |
2.29175 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.29175 |
[BP] GO:0010675 |
None
|
ESRRB, PPARA, PTAFR, RORC, SRC |
2.26154 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25724 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2547 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.2547 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.2547 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2547 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADORA2A, ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DNMT1, EGFR, ERBB2, IGF1R, KDR, MET, PTAFR, PTPN1, SRC |
2.25028 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CDK6, CYP19A1, ERBB2, ESR1, ESRRA, HCAR2, MMP2, PTAFR, PTPN1, SRC |
2.24838 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, IGF1R, MMP2, PTAFR, SRC |
2.23205 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
ADORA2A, BCL2, KDR, SRC |
2.23205 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.23205 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.23205 |
[BP] GO:0097746 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR |
2.23205 |
[BP] GO:0035296 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR |
2.23205 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, APP, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, KDR, PIM1, PPARA, RORC, SRC, TERT, TNKS2, XDH |
2.23205 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, EGFR, ERBB2, FLT3, KDR, PTPN1, SRC, XDH |
2.23205 |
[BP] GO:0061900 |
None
|
ADORA2A, APP, EGFR |
2.22518 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22518 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.22226 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.20612 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.2019 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.19581 |
[BP] GO:0003013 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR, SRC |
2.19581 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, XDH |
2.18834 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
ADORA2A, CSNK2A1, F3, MMP9, SRC, XDH |
2.18834 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ADORA2A, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, ESR1, FLT3, FUT7, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PTPN1, SRC, TNKS, TNKS2 |
2.17877 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, BCL2, TNKS2 |
2.17877 |
[BP] GO:0045913 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.15769 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR |
2.1476 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADORA2A, APP, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, PTPN1, SRC |
2.1469 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.14212 |
[BP] GO:0050880 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR |
2.13383 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, EGFR, PIM1, TERT, TNKS |
2.12709 |
[BP] GO:0035150 |
None
|
ADORA1, ADORA2A, ADRB1, EGFR, PTAFR |
2.12239 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, MET |
2.10275 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.1027 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.09675 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.093 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.093 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.093 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, MET, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.093 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.09117 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.08985 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.08184 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADORA2A, APP, CA2, CACNA1C, EGFR, ERBB2, HCAR2, PTPN1, SRC |
2.06337 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
ADORA2A, APP, AURKB, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.06114 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.06114 |
[BP] GO:0001775 |
cell activation
|
ADORA2A, ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, MMP9, PTAFR, RORC, SRC |
2.05794 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, IGF1R, MMP2, PTAFR, SRC |
2.05643 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.04706 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.04642 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HSD11B2, SRC, TYR |
2.03363 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.03363 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.01204 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, SRC, TERT, TNKS, TNKS2, TYR |
3.81099 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, ESR1, F3, FLT3, GBA2, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, SRC, TERT |
3.27248 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.97983 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, PTAFR, PTPN1, SRC, TYR |
2.53269 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.4895 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.4895 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.36994 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MMP2, MMP9, PIM1, PTAFR, PTPN1, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.21126 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2 |
2.1941 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, F3, MET |
2.08667 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
14.9226 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
10.5832 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TNKS, TNKS2, TYR, XDH |
10.5832 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.82778 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
6.5646 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.53466 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.17025 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.91578 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.69698 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.62642 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
5.51442 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.44534 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.3315 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
5.25549 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.25549 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
5.24803 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.17387 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.17387 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
5.13898 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.06303 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.96265 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.89483 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.77088 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, CDK6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.60709 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
4.19725 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC |
4.13541 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.12264 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
4.0594 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.99442 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.95726 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, PTAFR, RORC |
3.91921 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B2, HSD17B1, SRC, XDH |
3.76736 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.68434 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR, RORC |
3.67576 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.65877 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3, PTAFR |
3.59293 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.48342 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADORA2A, AOX1, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, TERT, TYR, XDH |
3.44769 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.3777 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
3.35755 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.35755 |
[MF] GO:0019899 |
enzyme binding
|
ADORA2A, ADRB1, APP, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRB, F3, MET, PPARA, PTAFR, PTPN1, SRC, TNKS2 |
3.31437 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.30989 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.30762 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.14966 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.99601 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TERT |
2.92347 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.9023 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.9023 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.9023 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75481 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.6625 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PTPN1 |
2.61809 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.45916 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.45848 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.41245 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.30579 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2547 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.16502 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.16361 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.13156 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PTAFR |
2.10814 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PTAFR |
2.10814 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.093 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, F3, FLT3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC |
2.01866 |
[MF] GO:0043168 |
anion binding
|
ABCB1, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, PTAFR, SRC, XDH |
2.01204 |